ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.
Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong philipli@cuhk.edu.hk.
Philip Kam-Tao
PK
Li
Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
Cheuk Chun
CC
Szeto
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Beth
B
Piraino
Department of Nephrology, Hospital Privado and Catholic University, Cordoba, Argentina.
Javier
J
de Arteaga
Department of Renal Medicine and Transplantation, Barts Health NHS Trust, London, UK.
Stanley
S
Fan
Nursing School-FAENFI, Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Brazil.
Ana E
AE
Figueiredo
Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA.
Douglas N
DN
Fish
Department of Nephrology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Belgium.
Eric
E
Goffin
Department of Internal Medicine, Kyungpook National University School of Medicine, Clinical Research Center for End Stage Renal Disease, Daegu, Korea.
Yong-Lim
YL
Kim
University of Missouri-Columbia School of Medicine, Department of Internal Medicine, Section of Infectious Disease, MI, USA.
William
W
Salzer
Department of Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Dirk G
DG
Struijk
University of Colorado Hospital, Aurora, CO, USA.
Isaac
I
Teitelbaum
Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia.
David W
DW
Johnson
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis / Q000379:methods; D002404:Catheterization / Q000009:adverse effects / Q000379:methods; D002408:Catheters, Indwelling; D005260:Female; D006801:Humans; D038622:Internationality; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D008297:Male; D010353:Patient Education as Topic / Q000379:methods; D010530:Peritoneal Dialysis / Q000009:adverse effects* / Q000379:methods; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000458:organization & administration; D011379:Prognosis; D018570:Risk Assessment; D012955:Societies, Medical; D015996:Survival Rate; D016896:Treatment Outcome
D000890:Anti-Infective Agents
ISPD; Peritonitis; guidelines; prevention; treatment